Speaker(s): 

Alexis (Lexy) Roman, Resident I, Staff Member, Geisinger - has nothing to disclose.

Moderator(s): 

Sarah F. Hale, PharmD, BCPPS, Director of Pharmacy, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Review current evidence-based approach to rapid sequence intubation (RSI) in pediatric emergency department patients.
• Compare the pharmacology, clinical efficacy, and safety considerations of succinylcholine and rocuronium. 
• Evaluate a current clinical trial comparing these two agents in pediatric RSI.
• Apply evidence and guideline recommendations to patient specific scenarios.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Sarah F. Hale, PharmD, Brian Simpkins, PharmD, Jessica Milheim, CPhT, Clara Bishay, PharmD, and Simran Kaur, PharmD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None.